Your browser doesn't support javascript.
loading
Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
Lebdai, Souhil; Mathieu, Romain; Leger, Julie; Haillot, Olivier; Vincendeau, Sébastien; Rioux-Leclercq, Nathalie; Fournier, Georges; Perrouin-Verbe, Marie-Aimée; Doucet, Laurent; Azzouzi, Abdel Rahmene; Rigaud, Jérome; Renaudin, Karine; Charles, Thomas; Bruyere, Franck; Fromont, Gaelle.
Afiliación
  • Lebdai S; Urology Department, University Hospital of Angers, Angers, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France. Electronic address: souhil.lebdai@gmail.com.
  • Mathieu R; Urology Department, University Hospital of Rennes, Rennes, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Leger J; Inserm CIC, Tours, France.
  • Haillot O; Urology Department, University Hospital of Tours, Tours, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Vincendeau S; Urology Department, University Hospital of Rennes, Rennes, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Rioux-Leclercq N; Pathology Department, University Hospital of Rennes, Rennes, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Fournier G; Urology Department, University Hospital of Brest, Brest, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Perrouin-Verbe MA; Urology Department, University Hospital of Brest, Brest, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Doucet L; Pathology Department, University Hospital of Brest, Brest, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Azzouzi AR; Urology Department, University Hospital of Angers, Angers, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Rigaud J; Urology Department, University Hospital of Nantes, Nantes, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Renaudin K; Pathology Department, University Hospital of Nantes, Nantes, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Charles T; Urology Department, University Hospital of Poitiers, Poitiers, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Bruyere F; Urology Department, University Hospital of Tours, Tours, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
  • Fromont G; Pathology Department, University Hospital of Tours, Tours, France; ReSCaP prostate cancer network, Canceropôle Grand Ouest, France.
Urol Oncol ; 36(2): 80.e17-80.e24, 2018 02.
Article en En | MEDLINE | ID: mdl-29153942

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prostatectomía / Neoplasias de la Próstata / Síndrome Metabólico / HDL-Colesterol Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prostatectomía / Neoplasias de la Próstata / Síndrome Metabólico / HDL-Colesterol Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos